Table I.

Characteristics of synchronous primary endometrial and ovarian cancer (SPC) patients.

No.	Age (years)	P	BMI	Symptom	Treatment	Menopause	Thrombosis	Corpus cancer stage	Ovarian cancer stage	Endometriosis	Recurrence	Overall survival (M)
1	48	2	24.6	Ab bleeding	CCS+che	Post	−	EC,G1(1a)	EC,G1(1a)	+	−	16
2	51	0	26.0	Abd distention	CCS+che	Pre	+	EC,G1(1a)	EC,G1(1c)	+	−	12
3	46	0	14.6	Elevated marker	CCS+che	Pre	−	EC,G1(1b)	EC,G1(2c)	+	−	18
4	43	2	19.2	Ab bleeding	CCS+che	Pre	−	EC,G1(1b)	EC,G1(2c)	+	−	14
5	46	0	24.7	Abd distention	TAH+BSO +pOM+chemo	Pre	+	EC,G1(1b)	EC,G1(2c)	+	−	11
6	57	0	17.1	Ab bleeding	CCS+che	Post	−	EC,G1(1a)	EC,G1(2a)	+	−	12
7	57	1	25.3	Residual urine	CCS+che	Post	−	EC,G1(2b)	EC,G1+CCC(2c)	+	+	61 (AWD)
8	50	2	21.2	Ab bleeding	CCS+che	Pre	+	EC,G1(2b)	EC,G1(1c)	+	−	57
9	61	2	24.6	Abd distention	CCS+che	Post	−	EC,G1(2b)	EC,G1(1c)	+	−	75
10	58	0	28.3	Ab bleeding	TAH+BSO+che	Post	+	EC,G1(3a)	EC,G1(1c)	+	−	45
11	52	2	19.5	Ab bleeding	TAH+BSO+che	Post	+	EC,G1(1a)	EC,G1(1c)	+	−	51
12	35	0	15.2	Abd distention, HNPCC	TAH+BSO+che	Pre	+	EC,G1(2a)	EC,G1(1c)	+	−	26
13	67	1	27.5	Ab bleeding	Che+CCS+che	Post	+	EC,G1(3)	CCC(2a)	+	+	63 (AWD)

P, parity; Ab bleeding, abnormal bleeding; Abd distention, abdominal distention; HNPCC, hereditary non-polyposis colorectal cancer; CCS, complete cytoreductive surgery; TAH, total abdominal hysterectomy; BSO, bilateral salphingo-oophorectomy; pOM, partial omentectomy; Che, chemotherapy; EC, endometrioid cancer; CCC, clear cell carcinoma; AWD, alive with disease.